J.ophthalmol.(Ukraine).2021;2:3-9.
http://doi.org/10.31288/oftalmolzh2021239
Received: 01 December 2020; Published on-line: 19 April 2021
Conjunctival cytology in patients treated for ocular infectious diseases
Sh. A. Dzhamalova, N. R. Yangieva, Z. Kh. Kuryazova
Tashkent State Dentistry Institute; Tashkent (Uzbekistan)
E-mail: shirinkon@mail.ru
TO CITE THIS ARTICLE: Dzhamalova ShA, Yangieva NR, Kuryazova ZKh. Conjunctival cytology in patients treated for ocular infectious diseases. J.ophthalmol.(Ukraine).2021;2:3-9.http://doi.org/10.31288/oftalmolzh2021239
Background: Anti-inflammatory therapy is a mainstay of treatment for patients with ocular inflammatory disorders. Although glucocorticosteroids (GCS) demonstrate a potent anti-inflammatory and anti-allergic effect, treatment with GCS is associated with a risk of serious side effects. Non-steroidal anti-inflammatory agents (NSAIDs) possess somewhat lower anti-inflammatory activity compared to GCS, and their development and incorporation into clinical eye care practice seem reasonable.
Purpose: To assess the efficacy of a 0.5% benzketosone ointment, a novel topical ocular medication manufactured in Uzbekistan, in the treatment of infectious conjunctivitis and blepharitis.
Material and Methods: One hundred and thirty-one patients (175 eyes; 64 men and 67 women) were included in this study to assess the efficacy of treatment with 0.5% benzketosone ointment (Certificate №06-07) for ocular inflammatory disorders. Patients of the control group received the conventional therapy, whereas those of the experimental group received 0.5% benzketosone ointment in addition to the conventional therapy. A modified impression cytology technique was used to monitor the therapeutic effect.
Results: Modified impression cytology showed that the incorporation of benzketosone ointment in the conventional treatment for conjunctivitis or blepharitis resulted in a substantial decrease in exudation and cell proliferation, which was manifested by a decrease in numbers of basophils and eosinophils, restoration of epithelial cell structure and earlier normalization of mean nucleocytoplasmic ratio values and earlier reduction in tissue and protein detritus in conjunctival specimens of the experimental group compared to controls.
Conclusion: Modified impression cytology provided evidence that the incorporation of benzketosone ointment in the conventional treatment for conjunctivitis or blepharitis improved regenerative activity, metabolic processes and symptoms of ocular inflammation.
Keywords: non-steroidal anti-inflammatory agents, conjunctivitis and blepharitis, conjunctival impression cytology
References
1.Dovgan’ EV. [Topical antimicrobial agents in ophthalmology: a review]. Ophthalmology in Russia. 2014;11(2):10-8. Russian.
2.Maichuk DIu. [Infectious ocular surface disorders (conjunctivitis and keratitis)]. In: [Maichuk DIu, editor. Red eye syndrome]. Moscow: Media Sfera; 2010. Russian.
3.Maichuk IuF. [Current medication therapy for conjunctivitis: a guide for physicians]. Moscow; 2013. Russian.
4.Neroev VV. [Guidelines for further development of the eye care service in the Russian Federation]. In: [Proceedings of the 9th Russian Ophthalmology Congress]. Moscow; 2010. p. 52-55. Russian.
5.Neroev VV, Maichuk IuF. [Diseases of the conjunctiva]. In: [Short National Guidelines on Eye Disease Management]. Moscow; 2014. p. 367-407. Russian.
6.Sidikov ZU. [Achievements and problems of the eye care service in the Republic of Uzbekistan]. Organizaziia i upravleniie zdravookhraneniiem. Tashkent. 2012;10:41-50. Russian.
7.Maichuk IuF. [Current therapeutic potential toward conjunctivitis]. In: [Proceedings of the 17th Russian National Congress on “Man and medications”]. 12-16 April, 2010. Moscow. p.215-225. Russian.
8.Maichuk IuF, Iani EV. [Novel approaches to the treatment of blepharitis]. Kataraktalnaia i refraktsionnaia khirurgiia. 2012;12(1):59-62. Russian.
9.Behrens-Baumann W. Topical antimycotic drugs. In: Kramer A, Behrens-Baumann W, editors. Antiseptic prophylaxis and therapy in ocular infections. Karger; 2002. p.263–80. Crossref PubMed
10.Larcombe J. Review: antibiotic therapy leads to slightly earlier recovery in acute bacterial conjunctivitis. Evid Based Med. 2006 Dec;11(6):180.
11.Kaercher T, Buchholz P, Kimmich F. Treatment of patients with keratoconjunctivitis sicca with OPtive: results of a multicenter, open-label observational study in Germany. Clin Ophthalmol. 2009;3:33–9. Crossref PubMed
12.Slonimskii AIu, Slonimskii IuB, Obrubov AS. [A novel non-steroidal anti-inflammatory agent for the treatment of various eye disorders]. Ophthalmology in Russia. 2016;13(1):33-7. Russian. https://doi: 10.18008 / 1816 5095 2016-33-37.
13.Razumova IIu, Godzenko AA. [Non-steroidal anti-inflammatory agent for the treatment of anterior uveitis associated with spondyloarthritis]. 2020;5(136):70-7. Russian.
14.Astakhov IuS, Riks IA. [Current methods for the diagnosis and treatment of conjunctivitis]. St Petersburg: Pavlov Medical University; 2007. Russian.
15.Eremenko AI, Ianchenko SV, Kiseliov AV. [Modified impression cytology for patients with dry eye secondary to topical ophthalmic preservatives]. Kubanskii nauchnyi meditsinskii vestnik. 2009;9(114):48-50. Russian.
16.Petraievskii AV, Trishkin KS. [Clinical and cytological diagnosis of dey eye]. Vestnik VolgGMU. 2012;4(44):52-4. Russian.
17.Ianchenko SV. [Modified impression cytology for patients with dry eye associated with chronic ocular ischemic syndrome]. Vestnik novykh meditsinskikh tekhnologii. 2009;16(1):149. Russian.
18.Vorontsova TN, Brzheskiy VV, Mikhailova MV. [Microflora of conjunctiva in children and its sensitivity and resistance to antibacterial drugs]. Ophthalmology in Russia. 2012;9(1):10-8. Russian.
Conflict of interests: All authors declare no conflict of interests.